Choose Your language:
- Testimonials
-
i have recept my viagra thanks you
- robert
Read more »
Our billing is certified by:
- News
-
- FDA approved Tadalafil medication for the treatment of erectile dysfunction accompanied with primary and secondary symptoms of benign prostatic hyperplasia (BPH) in men above 45 years.
- Considering the information of three randomized, multicenter, double, blind clinical studies and a retrospective analysis of the medical documentation, FDA approved on October 7, 2011 Tadalafil medication for the treatment of erectile dysfunction accompanied with primary and secondary symptoms of benign prostatic hyperplasia (BPH) in men above 45 years
- The forming, development and monitoring of the pharmaceutical market in USA in September 2011
- In spite of low rates and stagnation of industrial development, the pharmaceutical market shows a dynamical growth
- Sildenafil citrate and pulmonary arterial hypertension
- Pulmonary arterial hypertension Definition “pulmonary arterial hypertension” is related to a group of diseases characterized by: - Progressive increase in pulmonary vascular resistance; - Reduction in pulmonary bloodflow; - High pulmonary artery pressure; - Contractility of the heart right ventricle; - Right ventricular failure
- Fruit and vegetables do not reduce overall cancer risk, review concludes
- Eating lots of fruit and vegetables will do little to reduce your risk of developing cancer, according to a review of a decade of research involving more than a million people
- Common painkillers could be linked to male reproductive disorder
- The use of mild painkillers, such as paracetamol, in pregnancy – previously considered harmless to the baby in the womb – could be a major factor in the rise of male reproductive disorders, according to a study
-
- ZYTIGA® (abiraterone acetate) Data to be Presented at 2012 American Society of ... - EIN News (press release)
- ZYTIGA® (abiraterone acetate) Data to be Presented at 2012 American Society of
- Vivus Announces FDA Approval Of STENDRA(TM) (avanafil) Tablets For The ... - MarketWatch (press release)
- Vivus Announces FDA Approval Of STENDRA(TM) (avanafil) Tablets For The
- ZYTIGA® (Abirateronacetat)-Daten werden auf der Jahrestagung 2012 der American ... - Prestige Cars Magazin
- ZYTIGA® (Abirateronacetat)-Daten werden auf der Jahrestagung 2012 der American
- COMUNICADO: Los datos de ZYTIGA® serán presentados en la Reunión Anual 2012 de ... - Europa Press
- COMUNICADO: Los datos de ZYTIGA® serán presentados en la Reunión Anual 2012 de
- Los datos de ZYTIGA® serán presentados en la Reunión Anual 2012 de ASCO - PR Newswire (Comunicado de prensa)
- Los datos de ZYTIGA® serán presentados en la Reunión Anual 2012 de ASCOPR Newswire (Comunicado de prensa)El uso de inhibidores de CYP3A4 fuertes (como ketoconazole, itraconazole, clarithromycin, atazanavir, nefazodona, saquinavir, telithromycin, ritonavir, indinavir, nelfinavir, voriconazole) o inductores (como fenitoin, carbamazepina, rifampicin,
